EN
HI
Summary
As of 31 Aug, 2026, Mankind Pharma stock price is ₹2357.4. During the trading session, the stock has moved between an intraday low of ₹2346.10 and an intraday high of ₹2407.60. Over the last 52 weeks, Mankind Pharma has traded between ₹1909.70 and ₹2674.00.
The stock has recorded a trading volume of 2,10,113 shares, with a market capitalization of ₹412995978. Its Average Traded Price (ATP) is ₹2362.59, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2357.40.
Mankind Pharma has an upper circuit limit of ₹2621.10 and a lower circuit limit of ₹2144.70. The total value traded stands at ₹49.64 CR, and the delivery percentage for the day is 54.84%.
The stock is currently traded with a market lot size of 1. Mankind Pharma also offers a dividend yield of 0.04%.
Mankind Pharma share price chart
Mankind Pharma Share Key Metrics
Volume
2.10 L
Market Cap
98412.81 CR
LTQ@LTP
2@2357.40
ATP
2362.59
Var Margin
14.22 %
Circuit Range
2144.7-2621.1
Delivery %
54.84 %
Value
49.64 CR
ASM/GSM
No
Market Lot
1
Mankind Pharma Fundamentals
P/E Ratio
48.27
P/B Ratio
5.86
Div. Yield
0.04
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Mankind Pharma Resistance and Support
Pivot 2391.67
Resistance
First Resistance
2413.34
Second Resistance
2443.77
Third Resistance
2465.44
Support
First Support
2361.24
Second Support
2339.57
Third Support
2309.14
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
29SEP26
2373.70
-33.90 (1.41%)
27OCT26
2385.80
-31.80 (1.32%)
23NOV26
2389.80
-35.20 (1.45%)
MANKIND|29SEP26 CE 2340.00
0.00
-337.4 (-100%)
MANKIND|29SEP26 PE 2360.00
51
13.5 (36%)
Mankind Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 2407.6 | 2357.4 | -1.07% | 2407.6 | 2346.1 |
| Fri Aug 28 2026 | 2419 | 2382.89 | -1.43% | 2422.1 | 2370 |
| Thu Aug 27 2026 | 2405 | 2417.5 | 0.99% | 2417.5 | 2377.6 |
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Restructuring
Mankind Pharma's Board approved a scheme for the voluntary liquidation of its wholly-owned subsidiary, Bharat Serums and Vaccines Ltd (BSVL). This scheme aims to consolidate BSVL's business into the company, improving operational efficiency, cash management, and reducing compliance costs.
Aug 26 2026 16:43:03
Mankind Pharma Ltd - 543904 - Board Meeting Outcome for Dated August 26, 2026
Mankind Pharma's Board approved the voluntary liquidation of its material wholly owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), for business consolidation. This move aims to drive operational efficiency and improve execution capabilities.
Aug 26 2026 16:38:13
Read More
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Cipla Ltd.
1415.20
-8.30 (0.58%)
Lenskart Solutions Ltd.
654.55
18.40 (2.89%)
Laurus Labs Ltd.
1890.70
-47.80 (2.47%)
Manipal Health Enterprises Ltd.
762.40
-9.25 (1.20%)
Lupin Ltd.
2163.40
-8.10 (0.37%)
Max Healthcare Institute Ltd.
1010.80
-3.30 (0.33%)
Dr. Reddy's Laboratories Ltd.
1175.20
-2.80 (0.24%)
Aurobindo Pharma Ltd.
1683.90
38.60 (2.35%)
Glenmark Pharmaceuticals Ltd.
2485.30
-29.70 (1.18%)
Fortis Healthcare Ltd.
911.90
-14.85 (1.60%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2357.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 48.27. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 5.86. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 98412.81 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2674.00 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
